Haisar Dao Campi, MD
Colon & Rectal Surgery · McAllen, TXNPI 1144493891
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (47.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 75.0% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2022 at $4,380 and has fallen 89.2% since, to $472 in 2025.
Across 59 payments — averaging $108.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$5K
- Imbed Biosciences Inc.$522
- Boston Scientific$387
- Covidien LP$260
- Phathom Pharmaceuticals, Inc.$125
- Mimedx Group, Inc.$115
- plus $193 from 8 others
What the payments were for
- Consulting fees$2464%
- Travel & lodging$79212%
- Food & beverage$2,31136%
- Education$3,04648%
- Gifts$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 22 | $4,807 |
| Imbed Biosciences Inc. | 22 | $522 |
| Boston Scientific | 3 | $387 |
| Covidien LP | 2 | $260 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Mimedx Group, Inc. | 1 | $115 |
| Acell, Inc. | 1 | $37 |
| Medtronic | 1 | $26 |
| Janssen Scientific Affairs, LLC | 1 | $26 |
| Pacira Pharmaceuticals Incorporated | 1 | $22 |
| Heron Therapeutics, Inc. | 1 | $22 |
| Integra Lifesciences Corporation | 1 | $21 |
| Conmed Corporation | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$3,000
- Da Vinci Surgical System$983
- Axonics$387
- VOQUEZNA$125
How this compares
$6,410 in reported general payments places this provider in the 60th percentile of 200 colon & rectal surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin Sulfate | 24 | $127 |
| Metronidazole | 15 | $16 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in McAllen
- Alberto PenaMcAllen$59K
- Dustin LuebbersMcAllen$49K
- Thiru LakshmanAustin$756K
- Diego Marines CopadoHouston$462K
- Bidhan DasSugar Land$350K
- Christopher de JesusSan Antonio$201K
- Farshid AraghizadehFort Worth$181K
- Jefferson HurleyIrving$163K
- Erik AskenasyHouston$142K
- Eric HaasHouston$140K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.